Article Details
Retrieved on: 2024-08-10 00:01:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Biopharmaceutical. According to Merck, full rights will be acquired through a subsidiary, providing Curon with an upfront payment of $700 million ...
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here